By: Benzinga
December 28, 2012 at 08:14 AM EST
Benzinga's Top Pre-Market Gainers
Aeterna Zentaris (NASDAQ: AEZS ) added 4.15% to $2.26 in the pre-market session. Aeterna Zentaris granted Special Protocol Assessment by the U.S. Food and Drug Administration for Phase 3 registration trial in endometrial cancer with AEZS-108. Arena Pharmaceuticals (NASDAQ: ARNA ) moved up 1.71% to $8.94 in the pre-market
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here